Influence of Spinal Cord Stimulation on Insulin Sensitivity in Chronic Pain Patients

Abstract

Background and Objective This prospective, sham-controlled, randomized, cross-over study (NCT03637075), was designed to test the hypothesis that spinal cord stimulation (SCS) for the treatment of pain can also improve glucose metabolism and insulin sensitivity when compared to sham stimulation.

Methods Ten non-diabetic participants (5 females, mean age 48.8 years) who had an SCS system implanted for the treatment of chronic neuropathic pain were studied. Whilst applying a hyperinsulinemic-euglycemic clamp, sham-stimulation and tonic stimulation were performed for 45 min (n=4) or 60 min (n=6) in each case randomly. The insulin sensitivity index and pain levels were determined. A second investigation, BurstDR stimulation was also conducted and the result was compared to that of sham stimulation (cross-over design).

Results The insulin sensitivity improved significantly under the tonic stimulation when compared to the sham stimulation (p=0.037). BurstDR stimulation independently did not lead to a significantly improved insulin sensitivity compared to that after sham stimulation (p=0.16). We also examined the pain during the test and found no significant difference between sham and tonic stimulation (p=0.687).

Conclusion The results of this study show that tonic stimulation used for the treatment of pain could also improve glucose metabolism and insulin sensitivity. Further investigations are required to investigate the clinical relevance of the role of glucose metabolism in diabetic chronic pain participants and its underlying mechanisms.

Key words

glucose level - tonic stimulation - BurstDR stimulation - neuropathic pain - sympathetic nervous system - insulin

Publication History

Received: 06 March 2021
Received: 06 May 2021

Accepted: 27 May 2021

Article published online:
12 July 2021

• Literature

• 1 Cameron T. Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20-year literature review. J Neurosurg 2004; 100: 254-267
• 2 De Ridder D, Plazier M. Kamerling. et al. Burst spinal cord stimulation for limb and back pain. World Neurosurg 2013; 80: 642-649
• 3 de Vos CC, Bom MJ, Vanneste S. et al. Burst spinal cord stimulation evaluated in patients with failed back surgery syndrome and painful diabetic neuropathy. Neuromodulation 2014; 17: 152-159
• 4 Berthoud HR, Neuhuber WL. Vagal mechanisms as neuromodulatory targets for the treatment of metabolic disease. Ann N Y Acad Sci 2019; 1454: 42-55
• 5 Kullmann S, Heni M, Hallschmid M. et al. Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans. Physiol Rev 2016; 96: 1169-1209
• 6 Ruud J, Steculorum SM, Bruning JC. Neuronal control of peripheral insulin sensitivity and glucose metabolism. Nat Commun 2017; 8: 15259
• 7 Teff KL. Visceral nerves: vagal and sympathetic innervation. JPEN J Parenter Enteral Nutr 2008; 32: 569-571
• 8 Oakley JC, Prager JP. Spinal cord stimulation: mechanisms of action. Spine (Phila Pa 1976) 2002; 27: 2574-2583
• 9 Boden G, Chen X, Urbain JL. Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production. Diabetes 1996; 45: 1044-1050
• 10 Benrick A, Kokosar M, Hu M. et al. Autonomic nervous system activation mediates the increase in whole-body glucose uptake in response to electroacupuncture. FASEB J 2017; 31: 3288-3297
• 11 Linderoth B, Gunasekera L, Meyerson BA. Effects of sympathectomy on skin and muscle microcirculation during dorsal column stimulation: animal studies. Neurosurgery 1991; 29: 874-879
• 12 Tanaka S, Barron KW, Chandler MJ. et al. Low intensity spinal cord stimulation may induce cutaneous vasodilation via CGRP release. Brain Res 2001; 896: 183-187
• 13 Heni M, Wagner R, Kullmann S. et al. Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men. Diabetes 2014; 63: 4083-4088
• 14 Macedo MP, Lima IS, Gaspar JM. et al. Risk of postprandial insulin resistance: the liver/vagus rapport. Rev Endocr Metab Disord 2014; 15: 67-77
• 15 Schlaich M, Straznicky N, Lambert E. et al. Metabolic syndrome: a sympathetic disease?. Lancet Diabetes Endocrinol 2015; 3: 148-157
• 16 Croom JE, Foreman RD, Chandler MJ. et al. Cutaneous vasodilation during dorsal column stimulation is mediated by dorsal roots and CGRP. Am J Physiol 1997; 272: H950-H957
• 17 Ahren B. Autonomic regulation of islet hormone secretion--implications for health and disease. Diabetologia 2000; 43: 393-410
• 18 Kapural L, Hayek SM, Stanton-Hicks M. et al. Decreased insulin requirements with spinal cord stimulation in a patient with diabetes. Anesth Analg 2004; 98: 745-746
• 19 Lee DY, Lee MY, Cho JH. et al. Decreased vagal activity and deviation in sympathetic activity precedes development of diabetes. Diabetes Care 2020; 43: 1336-1343